Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2024

Pfizer - Cyclin' Through Innovation: Next Generation CDKs in HR+ MBC

Mechanisms of resistance to CDK4/6 inhibition in HR+ MBC

Date

06 Dec 2024

Session

Pfizer - Cyclin' Through Innovation: Next Generation CDKs in HR+ MBC

Topics

Tumour Site

Breast Cancer

Presenters

Yoichi Naito

Authors

Y. Naito

Author affiliations

  • Department Of Developmental Therapeutics, National Cancer Center Hospital East, 277-8577 - Kashiwa/JP

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Welcome and introduction

Presenter: Soo Chin Lee

Session: Pfizer - Cyclin' Through Innovation: Next Generation CDKs in HR+ MBC

Resources:

Webcast

Q&A

Session: Pfizer - Cyclin' Through Innovation: Next Generation CDKs in HR+ MBC

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.